Demand for COVID-19 tests powers Abbott's forecast above estimate
- The company forecast adjusted earnings of at least $3.25 per share for the year after suspending its outlook in April due to uncertainties over the outbreak.
- Peer Quest Diagnostics Inc said earlier this week its second-quarter revenue would top analysts' estimates, largely due to growing demand for its COVID-19 tests.
